SCHEMBL23747321

SCHEMBL23747321

COc1ccc(CNC(=O)Nc2ccc(CN3CCCCC3=O)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.63
RAB9A P51151 4/20 0.59
NPC1 O15118 3/20 0.59
HDAC1 Q13547 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
HTT P42858 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
POLB P06746 1/20 0.54
MAPT P10636 2/20 0.53
NAMPT P43490 3/20 0.53
ROCK2 O75116 1/20 0.52
CHRM1 P11229 1/20 0.51
HTR2A P28223 1/20 0.51
MCHR1 Q99705 1/20 0.51
LMNA P02545 1/20 0.49
THRB P10828 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23747345 0.98 SMN1; SMN2 (0.66) SMN1; SMN2RAB9ANPC1HDAC1HDAC6
SCHEMBL23747324 0.86 CHRM1 (0.67) RAB9ANPC1MEN1KMT2AL3MBTL1
SCHEMBL23727723 0.86 SMN1; SMN2 (0.58) SMN1; SMN2RAB9ANPC1HDAC1HDAC6
SCHEMBL23727939 0.86 SMN1; SMN2 (0.58) SMN1; SMN2RAB9ANPC1HDAC1HDAC6
SCHEMBL23747448 0.85 CHRM1 (0.69) SMN1; SMN2RAB9ANPC1HDAC1HDAC6
SCHEMBL23747456 0.84 SMN1; SMN2 (0.56) SMN1; SMN2RAB9ANPC1HDAC1HDAC6
SCHEMBL23747457 0.84 SMN1; SMN2 (0.56) SMN1; SMN2RAB9ANPC1HDAC1HDAC6
SCHEMBL23747671 0.84 SMN1; SMN2 (0.56) SMN1; SMN2RAB9ANPC1HDAC1HDAC6
SCHEMBL23747674 0.84 SMN1; SMN2 (0.56) SMN1; SMN2RAB9ANPC1HDAC1HDAC6
SCHEMBL26100733 0.84 SMN1; SMN2 (0.56) SMN1; SMN2RAB9ANPC1HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
WO-2021159015-A1 NAMPT MODULATORS CYTOKINETICS, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 SMN1; SMN2 1161/4885RAB9A 807/4885NPC1 463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.